Primary spinal cord glioma: A Surveillance, Epidemiology, and End Results database study

Michael T. Milano, Mahlon Johnson, Joohee Sul, Nimish A. Mohile, David N. Korones, Paul Okunieff, Kevin A. Walter

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

To characterize the overall survival (OS) and cause specific survival (CSS), and variables affecting outcome, in patients with primary spinal cord astrocytoma (SCA) and ependymoma (SCE). About 664 patients with SCA and 1,057 patients with SCE were analyzed using the Surveillance, Epidemiology, and End Results database. For grade 1, 2, 3 and 4 SCA, the 5-year OS was 82, 70, 28 and 14%; the 5-year CSS was 89, 77, 36 and 20%. For SCA, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for CSS. Smaller tumor size also improved survival. For grade 1, 2, and 3 SCE, the 5-year OS was 92, 97 and 58%; the 5-year CSS was 100, 98 and 64%. For SCE, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for OS. Smaller tumor size did not confer a survival benefit. Patients with resected grade 2 spinal cord glioma who did not receive radiotherapy fared well with respect to OS and CSS. For patients with spinal cord glioma, the variables of histology, grade, age and undergoing resection are significant predictors of outcome. Though treatment with radiotherapy was associated with worse outcomes, this may reflect a bias in that patients who underwent radiotherapy were perhaps more likely to have had adverse risk factors. Given the retrospective nature of this study, specific recommendations about which situations warrant radiotherapy cannot be determined.

Original languageEnglish (US)
Pages (from-to)83-92
Number of pages10
JournalJournal of Neuro-Oncology
Volume98
Issue number1
DOIs
StatePublished - May 1 2010

Fingerprint

Glioma
Spinal Cord
Epidemiology
Databases
Survival
Ependymoma
Radiotherapy
Astrocytoma
Neoplasms
Histology
Therapeutics
Retrospective Studies

All Science Journal Classification (ASJC) codes

  • Oncology
  • Neurology
  • Clinical Neurology
  • Cancer Research

Cite this

Primary spinal cord glioma : A Surveillance, Epidemiology, and End Results database study. / Milano, Michael T.; Johnson, Mahlon; Sul, Joohee; Mohile, Nimish A.; Korones, David N.; Okunieff, Paul; Walter, Kevin A.

In: Journal of Neuro-Oncology, Vol. 98, No. 1, 01.05.2010, p. 83-92.

Research output: Contribution to journalArticle

Milano, Michael T. ; Johnson, Mahlon ; Sul, Joohee ; Mohile, Nimish A. ; Korones, David N. ; Okunieff, Paul ; Walter, Kevin A. / Primary spinal cord glioma : A Surveillance, Epidemiology, and End Results database study. In: Journal of Neuro-Oncology. 2010 ; Vol. 98, No. 1. pp. 83-92.
@article{2fa7093162e8439aa70dcb1be746fc2f,
title = "Primary spinal cord glioma: A Surveillance, Epidemiology, and End Results database study",
abstract = "To characterize the overall survival (OS) and cause specific survival (CSS), and variables affecting outcome, in patients with primary spinal cord astrocytoma (SCA) and ependymoma (SCE). About 664 patients with SCA and 1,057 patients with SCE were analyzed using the Surveillance, Epidemiology, and End Results database. For grade 1, 2, 3 and 4 SCA, the 5-year OS was 82, 70, 28 and 14{\%}; the 5-year CSS was 89, 77, 36 and 20{\%}. For SCA, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for CSS. Smaller tumor size also improved survival. For grade 1, 2, and 3 SCE, the 5-year OS was 92, 97 and 58{\%}; the 5-year CSS was 100, 98 and 64{\%}. For SCE, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for OS. Smaller tumor size did not confer a survival benefit. Patients with resected grade 2 spinal cord glioma who did not receive radiotherapy fared well with respect to OS and CSS. For patients with spinal cord glioma, the variables of histology, grade, age and undergoing resection are significant predictors of outcome. Though treatment with radiotherapy was associated with worse outcomes, this may reflect a bias in that patients who underwent radiotherapy were perhaps more likely to have had adverse risk factors. Given the retrospective nature of this study, specific recommendations about which situations warrant radiotherapy cannot be determined.",
author = "Milano, {Michael T.} and Mahlon Johnson and Joohee Sul and Mohile, {Nimish A.} and Korones, {David N.} and Paul Okunieff and Walter, {Kevin A.}",
year = "2010",
month = "5",
day = "1",
doi = "10.1007/s11060-009-0054-7",
language = "English (US)",
volume = "98",
pages = "83--92",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Primary spinal cord glioma

T2 - A Surveillance, Epidemiology, and End Results database study

AU - Milano, Michael T.

AU - Johnson, Mahlon

AU - Sul, Joohee

AU - Mohile, Nimish A.

AU - Korones, David N.

AU - Okunieff, Paul

AU - Walter, Kevin A.

PY - 2010/5/1

Y1 - 2010/5/1

N2 - To characterize the overall survival (OS) and cause specific survival (CSS), and variables affecting outcome, in patients with primary spinal cord astrocytoma (SCA) and ependymoma (SCE). About 664 patients with SCA and 1,057 patients with SCE were analyzed using the Surveillance, Epidemiology, and End Results database. For grade 1, 2, 3 and 4 SCA, the 5-year OS was 82, 70, 28 and 14%; the 5-year CSS was 89, 77, 36 and 20%. For SCA, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for CSS. Smaller tumor size also improved survival. For grade 1, 2, and 3 SCE, the 5-year OS was 92, 97 and 58%; the 5-year CSS was 100, 98 and 64%. For SCE, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for OS. Smaller tumor size did not confer a survival benefit. Patients with resected grade 2 spinal cord glioma who did not receive radiotherapy fared well with respect to OS and CSS. For patients with spinal cord glioma, the variables of histology, grade, age and undergoing resection are significant predictors of outcome. Though treatment with radiotherapy was associated with worse outcomes, this may reflect a bias in that patients who underwent radiotherapy were perhaps more likely to have had adverse risk factors. Given the retrospective nature of this study, specific recommendations about which situations warrant radiotherapy cannot be determined.

AB - To characterize the overall survival (OS) and cause specific survival (CSS), and variables affecting outcome, in patients with primary spinal cord astrocytoma (SCA) and ependymoma (SCE). About 664 patients with SCA and 1,057 patients with SCE were analyzed using the Surveillance, Epidemiology, and End Results database. For grade 1, 2, 3 and 4 SCA, the 5-year OS was 82, 70, 28 and 14%; the 5-year CSS was 89, 77, 36 and 20%. For SCA, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for CSS. Smaller tumor size also improved survival. For grade 1, 2, and 3 SCE, the 5-year OS was 92, 97 and 58%; the 5-year CSS was 100, 98 and 64%. For SCE, lower grade, younger age, and undergoing resection significantly improved OS and CSS; treatment without radiotherapy was favorable for OS. Smaller tumor size did not confer a survival benefit. Patients with resected grade 2 spinal cord glioma who did not receive radiotherapy fared well with respect to OS and CSS. For patients with spinal cord glioma, the variables of histology, grade, age and undergoing resection are significant predictors of outcome. Though treatment with radiotherapy was associated with worse outcomes, this may reflect a bias in that patients who underwent radiotherapy were perhaps more likely to have had adverse risk factors. Given the retrospective nature of this study, specific recommendations about which situations warrant radiotherapy cannot be determined.

UR - http://www.scopus.com/inward/record.url?scp=77953609734&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953609734&partnerID=8YFLogxK

U2 - 10.1007/s11060-009-0054-7

DO - 10.1007/s11060-009-0054-7

M3 - Article

C2 - 19898743

AN - SCOPUS:77953609734

VL - 98

SP - 83

EP - 92

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -